These data suggest that epigenetically upregulated oncoprotein PLCE1 can activate the NF-κB signaling pathway and may promote angiogenesis and cause poor clinical outcomes in ESCC (Fig. 7e). Here, NFKB1 is linked to esophageal squamous cell carcinoma.